deoxyuridine triphosphatase inhibitors (Taiho Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedeoxyuridine triphosphatase inhibitors (Taiho Pharmaceutical)
Drug Alias NamedUTPase inhibitors (Taiho Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActiondUTP pyrophosphatase inhibitors
TargetsdUTP pyrophosphatase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOtsuka Holdings Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka Holdings Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A